Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 92

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 92
---
 There can be no assurance that the Closing conditions will be satisfied or waived or that the transactions will be completed. See the risk factor below titled “The announcement and pendency of the Merger Agreement and any subsequent termination of the Merger Agreement could negatively affect the stock price and the future business and financial results of TuHURA or Kineta.”

In the event that the parties determine to waive any of the conditions to the completion of the Mergers, such decision may have an adverse effect on TuHURA and Kineta and their respective stockholders. For example, if**

<div align='center'>48</div>

Kineta waives the condition that there be no material adverse effect on TuHURA that has occurred and is continuing, the value of the consideration received by Kineta stockholders could be materially diminished. In addition, under specified circumstances, including termination of the Merger Agreement by Kineta to accept and enter into a definitive agreement with respect to a Superior Proposal or by TuHURA upon the change of the Kineta Board Recommendation, Kineta will be required to pay TuHURA a termination fee of $1,000,000 as described in the section entitled “The Merger Agreement—The Kineta Special Meeting; TuHURA Special Meeting; Kineta Board Recommendation”. In addition, the Merger Agreement provides that TuHURA will be required to pay to Kineta a termination fee of $1 million if the Merger Agreement is terminated by Kineta when all of the conditions to Closing have been satisfied except for the completion and receipt of funds pursuant to the Concurrent Investment and TuHURA is incapable of satisfying such condition before June 30, 2025, provided, that TuHURA may, on or prior to June 30, 2025 by written notice to Kineta, extend the end date to no later than July 31, 2025, provided that as a condition to such extension, TuHURA shall advance to Kineta an amount equal to $250,000 to fund Kineta expenses, of which such amount shall not increase the Loaned Amount. Such termination fees may be inadequate to compensate the relevant party for the damage caused, and if available, other rights and remedies may be expensive and difficult to enforce, and the success of any such action may be uncertain. See the section entitled “The Merger Agreement—Termination of the Merger Agreement” and the section entitled “The Merger Agreement—Transaction Expenses and Termination Fees” for a more complete discussion of the circumstances under which